Author
Listed:
- Lifang Li
(Peking University Health Science Center)
- Xinhua Liu
(Tianjin Medical University)
- Lin He
(Peking University Health Science Center)
- Jianguo Yang
(Peking University Health Science Center)
- Fei Pei
(Peking University Health Science Center)
- Wanjin Li
(Peking University Health Science Center)
- Shumeng Liu
(Peking University Health Science Center)
- Zhe Chen
(Peking University Health Science Center)
- Guojia Xie
(Peking University Health Science Center)
- Bosen Xu
(Peking University Health Science Center)
- Xia Ting
(Peking University Health Science Center)
- Zihan Zhang
(Peking University Health Science Center)
- Tong Jin
(Peking University Health Science Center)
- Xujun Liu
(Peking University Health Science Center)
- Wenting Zhang
(Peking University Health Science Center)
- Shuai Yuan
(Peking University Health Science Center)
- Ziran Yang
(Peking University Health Science Center)
- Chongyang Wu
(Peking University Health Science Center)
- Yu Zhang
(Peking University Health Science Center)
- Xiaohan Yang
(Peking University Health Science Center)
- Xia Yi
(Peking University Health Science Center)
- Jing Liang
(Peking University Health Science Center)
- Yongfeng Shang
(Peking University Health Science Center
Tianjin Medical University)
- Luyang Sun
(Peking University Health Science Center)
Abstract
EGFR is required for animal development, and dysregulation of EGFR is critically implicated in malignant transformation. However, the molecular mechanism underlying the regulation of EGFR expression remains poorly explored. Here we report that the zinc-finger protein ZNF516 is a transcription repressor. ZNF516 is physically associated with the CtBP/LSD1/CoREST complex and transcriptionally represses a cohort of genes including EGFR that are critically involved in cell proliferation and motility. We demonstrate that the ZNF516–CtBP/LSD1/CoREST complex inhibits the proliferation and invasion of breast cancer cells in vitro and suppresses breast cancer growth and metastasis in vivo. Significantly, low expression of ZNF516 is positively associated with advanced pathological staging and poor survival of breast carcinomas. Our data indicate that ZNF516 is a transcription repressor and a potential suppressor of EGFR, adding to the understanding of EGFR-related breast carcinogenesis and supporting the pursuit of ZNF516 as a potential therapeutic target for breast cancer.
Suggested Citation
Lifang Li & Xinhua Liu & Lin He & Jianguo Yang & Fei Pei & Wanjin Li & Shumeng Liu & Zhe Chen & Guojia Xie & Bosen Xu & Xia Ting & Zihan Zhang & Tong Jin & Xujun Liu & Wenting Zhang & Shuai Yuan & Zir, 2017.
"ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin,"
Nature Communications, Nature, vol. 8(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00702-5
DOI: 10.1038/s41467-017-00702-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00702-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.